News | 2024 Nobel Prize awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.This year’s Nobel Prize focuses on the discovery of a vital regulatory mechanism used in cells to control gene activity. Genetic information flows from DNA to messenger RNA (mRNA), via a process called transcription, and then on to the cellular machinery for protein production.
Event | Controlling RNA Sequence for Diagnostics and Therapeutic Delivery | January 5-10, 2025
RNA Nanotechnology - Gordon Research Conference (GRC) Controlling RNA Sequence for Diagnostics and Therapeutic DeliveryJanuary 5 - 10, 2025
Ventura, California, United States
Congratulations to Dr. Raquel Cuella Martin on receiving Gairdner Foundation Early Career Investigator Award
Congratulations to Dr. Raquel Cuella Martin on receiving the prestigious Gairdner Foundation Early Career Investigator Award. As an Assistant Professor of Human Genetics at McGill University, Dr. Cuella Martin is pushing the boundaries of science with her lab, which uses precision genome editing to tackle complex biological problems.
News | Génome Québec invests up to $500,000 to boost RNA therapeutics innovation in Quebec
Génome Québec invests up to $500,000 to boost RNA therapeutics innovation in QuebecGénome Québec, a private, non-profit organization dedicated to advancing genomics research and innovation in Quebec, is investing up to $500,000 in McGill University’s D2R Initiative. This investment will advance the commercialization of innovative genomic technologies in Quebec through D2R’s Commercialization Priming funding program.
Event | Genes, genealogy, and geography: A genetic history of Quebec | Oct 3, 2024
Join McGill University Health Centre's next “Medical Genetics Grand Rounds”The founder effect, which is observed in certain regions of Quebec, can increase susceptibility to rare disease. This stems from the fact that these communities were founded by populations that were already related.
Event | Indigenous Perspectives on Truth and Reconciliation in Post-Secondary Education | Sept 30, 2024
In honour of National Day for Truth and Reconciliation, McGill's School of Continuing Studies is organizing an online panel discussion on Truth and Reconciliation within the post-secondary education system.
About the event:Title: Indigenous Perspectives on Truth and Reconciliation in Post-Secondary Education
Date & Time: Monday September 30, 2024 from 12-1pm
Format: On Zoom
News | D2R awards $7.3 million to Advance Research in Genomic-Based RNA Therapeutics
D2R awards $7.3 million to Advance Research in Genomic-Based RNA TherapeuticsMontreal – September 17, 2024 McGill University’s D2R initiative is proud to announce the 23 recipients of its inaugural funding programs, Foundational Projects and Research in Motion. With a total investment of $7.3 million, these awards mark a significant milestone in advancing the field of genomic-based RNA therapeutics.
News | Pleins feux sur la technologie ARN | La Presse
A recent article in La Presse, Pleins feux sur la technologie ARN, highlights how Quebec's life sciences sector is experiencing a significant revival with the creation of an RNA hub.
Here is a exerpt from the article (translated to english):
D2R Funding Opportunity | Core Platform Sustainability & Centres and Institutes Support
D2R | DNA to RNA, the research initiative at McGill University that is taking an inclusive Canadian approach to genomic-based RNA therapeutics is offering two new funding opportunities:
Event | Diversity, Equity, & Inclusion Workshop | Sept 23 at 10:30am
In this collaborative session you will learn about the value of Diversity Equity & Inclusion in the Institute of Genomic Medicine, how to access relevant resources through McGill services, and discuss real case studies to explore the ways McGill services and best practices can be applied to your workplace.
Event details:Title: Diversity, Equity, & Inclusion Workshop
Podcast | The Canadian Breakpoint with special guest Dr. Thomas Duchaine
In a recent episode of The Canadian Breakpoint podcast, Dr. Rupeena Purewal sits down with Dr. Thomas Duchaine, Director of McGill's Centre for RNA Sciences, to talk about the transformative potential of mRNA medicines. The episode explores how mRNA is emerging as a versatile therapeutic modality, with potential from vaccines to personalized medicine.
Event | Diet, Bodyweight and Cancer Risk - 2024 GCI Gairdner Symposium | Oct. 17-18, 2024
The 2024 Gairdner Symposium "Diet, Bodywieght and Cancer Risk", will be hosted by a world-leader in oncometabolism research, the Rosalind and Morris Goodman Cancer Institute.
Event | Vous êtes intéressés par les thérapies ARN ? | Sept 12, 2024
Find out more about AReNa - the Mobilizing RNA Project, and explore how you can contribute to the growth of Quebec's RNA industry!
This event will take place on Thursday September 12, 2024 and is being organized by CQDM.
News | Marking a new era in advancing genomic research at McGill
The McGill community, including researchers in genomic medicine and the health sciences, came together in July 2024 to mark the next phase of one of the University’s most rapidly growing disciplines and celebrate the generosity that is making it possible.
Article | "The 60-year evolution of lipid nanoparticles for nucleic acid delivery" in Nature Reviews Drug Discovery
Discover how lipid nanoparticles are transforming gene therapy in a new article co-authored by Pieter Cullis, Professor, Biochemistry and Molecular Biology at The University of British Columbia.
